Drug Search Results
More Filters [+]

Ibopamine

Alternative Names: ibopamine
Latest Update: 2021-04-03
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Epinine Analogue

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: India | Italy | Peru | Portugal

Approved Indications: None

Known Adverse Events: None

Company: John Landers
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Ibopamine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Glaucoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTRN12611001191987

P4

Completed

Glaucoma

2013-07-29

Predicting Glaucoma Progression

P4

Terminated

Glaucoma

2011-08-24

ACTRN12615000767505

P4

Not yet recruiting

Glaucoma

None

Recent News Events